FIELD: medicine, pharmaceutical industry. SUBSTANCE: invention relates to medicinal preparations covered by envelope and showing antiviral, antibacterial, anti-inflammatory and detoxifying effect. The medicinal preparation comprises recombinant alpha-, beta- or gamma-interferon, stabilizing agent of biological, physical-chemical properties and/or resistance against bacterial contamination and pharmaceutically acceptable special additions. The preparation can comprise additionally the following components: immunomodulating agent, ribavirin, vitamins, an anti-inflammatory preparation, riboxin. EFFECT: expanded assortment of medicinal agents. 17 cl, 8 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| CURATIVE AGENT | 2000 |
|
RU2187332C1 |
| ANTIVIRAL, ANTIBACTERIAL AND ANTICANDIDOSIS AGENT | 2000 |
|
RU2187328C1 |
| ANTIVIRAL AGENT | 2000 |
|
RU2187330C1 |
| MEDICINAL PREPARATION FOR PROPHYLAXIS AND TREATMENT OF INFECTIOUS DISEASES | 2001 |
|
RU2185840C1 |
| CONDOM LUBRICANT | 2000 |
|
RU2187329C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF CAPSULE POSSESSING ANTIVIRAL, ANTI-INFLAMMATORY, ANTIMICROBIAL AND IMMUNOMODULATORY ACTION | 2012 |
|
RU2482872C1 |
| SUPPOSITORY | 2006 |
|
RU2322968C1 |
| ANTIVIRAL MEDICATION - NASAL DROPS | 2010 |
|
RU2437676C1 |
| PHARMACEUTICAL COMPOSITION DENTOFERON IN FORM OF GEL FOR PREVENTING AND TREATING PERIODONTAL DISEASES | 2012 |
|
RU2490006C1 |
| ANTIVIRUS MEANS IN LIPOSOME FORM | 2000 |
|
RU2176518C1 |
